Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sexuality 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Postoperative Complications 1Lung Neoplasms 1Kidney Neoplasms 1Infertility 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dutasteride 3acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2proxalutamide 1polyphenon E 1mirabegron 1TroVax 1Transurethral Resection of Prostate 1Transurethral Resection of Bladder 1Therapeutics 1Tamsulosin 1Standard of Care 1Risedronic Acid 1Radiotherapy 1Psychiatric Rehabilitation 1Prostatectomy 1Papaverine 1Oxygen 1Nitrous Oxide 1Needles 1Microspheres 1Lycopene 1Levofloxacin 1Finasteride 1Electroacupuncture 1Doxazosin 1Docetaxel 1Diclofenac 1Dexmedetomidine 1Cystoscopy 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Prostatic Hyperplasia × Papaverine × Clear all
NCT03064282 2021-02-25

Prostatic Hyperplasia Treatment and Cancer Prevention

Manchanda Medical Clinic

Phase EARLY_PHASE1 Unknown
40 enrolled
Genitourinary

Prostatic Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡